347 related articles for article (PubMed ID: 36339964)
1. The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis.
Almulla AF; Thipakorn Y; Vasupanrajit A; Abo Algon AA; Tunvirachaisakul C; Hashim Aljanabi AA; Oxenkrug G; Al-Hakeim HK; Maes M
Brain Behav Immun Health; 2022 Dec; 26():100537. PubMed ID: 36339964
[TBL] [Abstract][Full Text] [Related]
2. The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis.
Almulla AF; Thipakorn Y; Vasupanrajit A; Tunvirachaisakul C; Oxenkrug G; Al-Hakeim HK; Maes M
Cells; 2022 Oct; 11(19):. PubMed ID: 36231075
[TBL] [Abstract][Full Text] [Related]
3. The tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta-analysis.
Almulla AF; Thipakorn Y; Tunvirachaisakul C; Maes M
Autism Res; 2023 Dec; 16(12):2302-2315. PubMed ID: 37909397
[TBL] [Abstract][Full Text] [Related]
4. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
Almulla AF; Vasupanrajit A; Tunvirachaisakul C; Al-Hakeim HK; Solmi M; Verkerk R; Maes M
Mol Psychiatry; 2022 Sep; 27(9):3679-3691. PubMed ID: 35422466
[TBL] [Abstract][Full Text] [Related]
5. The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis.
Almulla AF; Supasitthumrong T; Tunvirachaisakul C; Algon AAA; Al-Hakeim HK; Maes M
BMC Infect Dis; 2022 Jul; 22(1):615. PubMed ID: 35840908
[TBL] [Abstract][Full Text] [Related]
6. The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Almulla AF; Supasitthumrong T; Amrapala A; Tunvirachaisakul C; Jaleel AKA; Oxenkrug G; Al-Hakeim HK; Maes M
J Alzheimers Dis; 2022; 88(4):1325-1339. PubMed ID: 35786655
[TBL] [Abstract][Full Text] [Related]
7. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis.
Hebbrecht K; Skorobogatov K; Giltay EJ; Coppens V; De Picker L; Morrens M
Front Immunol; 2021; 12():667179. PubMed ID: 34093561
[TBL] [Abstract][Full Text] [Related]
9. Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression.
Comai S; Melloni E; Lorenzi C; Bollettini I; Vai B; Zanardi R; Colombo C; Valtorta F; Benedetti F; Poletti S
Eur Neuropsychopharmacol; 2022 Feb; 55():96-109. PubMed ID: 34847455
[TBL] [Abstract][Full Text] [Related]
10. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies.
Inam ME; Fernandes BS; Salagre E; Grande I; Vieta E; Quevedo J; Zhao Z
Braz J Psychiatry; 2023 May; 45(4):343-55. PubMed ID: 37127280
[TBL] [Abstract][Full Text] [Related]
11. Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders.
Li Y; Wang L; Huang J; Zhang P; Zhou Y; Tong J; Chen W; Gou M; Tian B; Li W; Luo X; Tian L; Hong LE; Li CR; Tan Y
Front Psychiatry; 2024; 15():1357293. PubMed ID: 38680780
[TBL] [Abstract][Full Text] [Related]
12. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder.
Poletti S; Melloni E; Aggio V; Colombo C; Valtorta F; Benedetti F; Comai S
J Affect Disord; 2019 Dec; 259():404-412. PubMed ID: 31610997
[TBL] [Abstract][Full Text] [Related]
13. Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways.
Anderson G; Jacob A; Bellivier F; Geoffroy PA
Curr Pharm Des; 2016; 22(8):987-1012. PubMed ID: 26654772
[TBL] [Abstract][Full Text] [Related]
14. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
[TBL] [Abstract][Full Text] [Related]
15. Reverse cholesterol transport and lipid peroxidation biomarkers in major depression and bipolar disorder: A systematic review and meta-analysis.
Almulla AF; Thipakorn Y; Algon AAA; Tunvirachaisakul C; Al-Hakeim HK; Maes M
Brain Behav Immun; 2023 Oct; 113():374-388. PubMed ID: 37557967
[TBL] [Abstract][Full Text] [Related]
16. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide.
Messaoud A; Mensi R; Douki W; Neffati F; Najjar MF; Gobbi G; Valtorta F; Gaha L; Comai S
World J Biol Psychiatry; 2019 Nov; 20(9):703-711. PubMed ID: 29683396
[No Abstract] [Full Text] [Related]
17. Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression.
Ormstad H; Dahl J; Verkerk R; Andreassen OA; Maes M
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1286-96. PubMed ID: 27237997
[TBL] [Abstract][Full Text] [Related]
18. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase (IDO)-activity in Severe Psychiatric Disorders: A Systemic Review.
Fellendorf FT; Bonkat N; Dalkner N; Schönthaler EMD; Manchia M; Fuchs D; Reininghaus EZ
Curr Top Med Chem; 2022; 22(25):2107-2118. PubMed ID: 35850653
[TBL] [Abstract][Full Text] [Related]
20. Linking nervous and immune systems in psychiatric illness: A meta-analysis of the kynurenine pathway.
Sales PMG; Schrage E; Coico R; Pato M
Brain Res; 2023 Feb; 1800():148190. PubMed ID: 36463958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
